Metabolomics Market Size, Share, Growth, Trend and Forecast
Metabolomics is a powerful and unique analytical approach for the systematic identification and quantification of small-molecule metabolites, metabolite target analysis, metabolic profiling, and metabolic fingerprinting in various biological systems and samples.
(firmenpresse) - The metabolomics market majorly comprises detection techniques such as mass spectrometry (MS) and nuclear magnetic resonance spectroscopy (NMR), and separation techniques such as gas chromatography. These techniques are used in metabolome studies, primarily in toxicology testing and developing personalized medicine.
This research report segments this Metabolomics Market based on product and service, application, indication, and region.
The growing focus on personalized medicine has driven the use of metabolomics tools by manufacturers engaged in developing rigorous strategies for understanding the root of a disease rather than simply treating a patient
Major Market Drivers in Metabolomics Market:
-Availability of government and private funding
Increasing pharmaceutical and biotech R&D expenditure
-Technological advancements
-Growing demand for personalized medicine
-Increasing use of metabolomics in toxicology testing
Key Market Growth Trend in Metabolomics:
The growing use of hyphenated technologies is likely to provide the largest growth opportunity for metabolomics market players.
Over the past four years, several hyphenated systems have been launched by market players. Hyphenated technology is a combination of two or more analytical tools. Hyphenated technologies reduce cost by requiring the installation of a single instrument. They also provide ease of operation and require lesser space as compared to the installation of two or more standalone devices. In addition, these technologies have broadened the applications of analytical techniques in the analysis of biomaterials, especially natural products.
Metabolomics Market Based on Application;
On the basis of application, the market is segmented into biomarker discovery, drug discovery, nutrigenomics, toxicology testing, personalized medicine, functional genomics, and others. the biomarker discovery segment accounted for the largest share of the global metabolomics market.
This is mainly attributed to the improvement in both the efficiency and reliability of metabolic profiling of biomarkers and the accurate and clinically useful diagnostic capabilities of metabolic biomarkers for the management of diseases at the metabolic level.
Major Key Players in Metabolomics Market;
Prominent players in the global metabolomics market are Thermo Fisher Scientific (U.S.), Agilent Technologies (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), and Shimadzu Corporation (Japan). Other leading players in this market include Bio-Rad Laboratories (U.S.), Bruker Corporation (U.S.),
Most of the leading players in this market are based in developed countries across North America and Europe.
Themen in dieser Pressemitteilung:
metabolomics
metabolomics-market
metabolomics-market-size
metabolomics-market-share
metabolomics-market-research
metabolomics-market-growth
metabolomics-industry
metabolomics-industry-analysis
metabolomics-market-key-players
metabolomics-market
Unternehmensinformation / Kurzprofil:
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales(at)marketsandmarkets.com
Datum: 25.04.2019 - 06:29 Uhr
Sprache: Deutsch
News-ID 1548767
Anzahl Zeichen: 3210
contact information:
Contact person: shelly singh
Town:
northbrook
Phone: 18886006441
Kategorie:
Biotech
Typ of Press Release: Financial
type of sending: send
Date of sending: 25.04.2019
Anmerkungen:
Diese Pressemitteilung wurde bisher 2193 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Metabolomics Market Size, Share, Growth, Trend and Forecast
"
steht unter der journalistisch-redaktionellen Verantwortung von
marketsandmarkets (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
